Balversa 4 MG
Ended Awarded
- Contract number
- 36C24525N0133
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $13,639
Award facts
- Contract value 100% obligated
- $13,639.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the oncology drug BALVERSA 4 MG, provided by Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc. The $13,639.07 firm fixed price delivery order was awarded on October 22, 2024 by the U.S. Department of Veterans Affairs (VA) to support its Veterans Integrated Service Network 5 (VISN 5).
Janssen Biotech, a subsidiary of Johnson & Johnson, is a major pharmaceutical manufacturer that specializes in developing and producing biologics for cancer, immunology, and infectious diseases. The company holds a $3.1 billion Federal Supply Schedule (FSS) contract with the VA for Pharmaceuticals and Drugs, as well as Blanket Purchase Agreements (BPAs) valued at $15 million and $3.7 million for BALVERSA and other oncology medications. These contract vehicles enable the VA and its VISNs to efficiently procure critical pharmaceuticals to support healthcare services for veteran patients nationwide. The contract award does not carry any set-aside designation.
Quick answers
Who was awarded contract 36C24525N0133?
36C24525N0133 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 22, 2024.
How much is contract 36C24525N0133 worth?
The government has obligated $13,639 on 36C24525N0133.
Is contract 36C24525N0133 an order under another contract?
Yes. 36C24525N0133 is a delivery order under 36F79724D0176, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0133 competed?
The extent of competition for 36C24525N0133 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award